TMPRSS2 and infection: The spike protein-mediated and TMPRSS2-dependent SARS-CoV-2 infection model with lung organoids was verified, and drugs that can prevent infection were tested by treating the cells with the TMPRSS2 inhibitor camostat, then quantifying luciferase activity.